Cerhan JR - Search Results

1

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.

Rossille D, Azzaoui I, Feldman AL, Maurer MJ, Labouré G, Parrens M, Pangault C, Habermann TM, Ansell SM, Link BK, Tarte K, Witzig TE, Lamy T, Slager SL, Roussel M, Milpied N, Cerhan JR, Fest T. Rossille D, et al. Among authors: cerhan jr. Leukemia. 2017 Apr;31(4):988-991. doi: 10.1038/leu.2016.385. Epub 2017 Jan 27. Leukemia. 2017. PMID: 28035137 Free PMC article. No abstract available.

2

Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women.

Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR. Parker AS, et al. Among authors: cerhan jr. Leuk Lymphoma. 2000 Apr;37(3-4):341-9. doi: 10.3109/10428190009089434. Leuk Lymphoma. 2000. PMID: 10752985

3

Role of HPC2/ELAC2 in hereditary prostate cancer.

Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Wang L, et al. Among authors: cerhan jr. Cancer Res. 2001 Sep 1;61(17):6494-9. Cancer Res. 2001. PMID: 11522646

4

Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States).

Cerhan JR, Habermann TM, Vachon CM, Putnam SD, Zheng W, Potter JD, Folsom AR. Cerhan JR, et al. Cancer Causes Control. 2002 Mar;13(2):131-6. doi: 10.1023/a:1014354105164. Cancer Causes Control. 2002. PMID: 11936819

5

Analysis of the RNASEL gene in familial and sporadic prostate cancer.

Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Wang L, et al. Among authors: cerhan jr. Am J Hum Genet. 2002 Jul;71(1):116-23. doi: 10.1086/341281. Epub 2002 May 17. Am J Hum Genet. 2002. PMID: 12022038 Free PMC article.

6

Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.

Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Am J Epidemiol. 2002 Sep 15;156(6):527-35. doi: 10.1093/aje/kwf082. Am J Epidemiol. 2002. PMID: 12226000

7

Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.

Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1466-71. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433728

8

Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.

Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM. Cerhan JR, et al. Int J Cancer. 2003 Sep 20;106(5):784-8. doi: 10.1002/ijc.11311. Int J Cancer. 2003. PMID: 12866040 Clinical Trial.

9

No association of germline alteration of MSR1 with prostate cancer risk.

Wang L, McDonnell SK, Cunningham JM, Hebbring S, Jacobsen SJ, Cerhan JR, Slager SL, Blute ML, Schaid DJ, Thibodeau SN. Wang L, et al. Among authors: cerhan jr. Nat Genet. 2003 Oct;35(2):128-9. doi: 10.1038/ng1239. Epub 2003 Sep 7. Nat Genet. 2003. PMID: 12958598

10

Clinical characteristics of familial vs. sporadic non-Hodgkin lymphoma in patients diagnosed at the Mayo Clinic (1986-2000).

Vachon CM, Habermann TM, Kurtin PJ, Cerhan JR. Vachon CM, et al. Among authors: cerhan jr. Leuk Lymphoma. 2004 May;45(5):929-35. doi: 10.1080/1042819032000159898. Leuk Lymphoma. 2004. PMID: 15291351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters